Clinical Trial Update: Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

This update concerns a Phase 4 trial evaluating the impact of saxagliptin on endothelial progenitor cells and endothelial function in newly diagnosed Type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED